Karen Valentine, VP and General Counsel at ANTIGENICS INC /DE/ (AGEN), sold 93,789 shares at $0.85 ($80K) on 2010-01-20, disclosed to the SEC on 2010-01-22.
Scheduled sale ($80k) by VP and General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CNST | SELL | 2020-04-29 | $16K | — | Filing → |
| CNST | SELL | 2020-04-22 | $27K | — | Filing → |
| CNST | SELL | 2020-04-20 | $247K | — | Filing → |